Evaluating digital adherence support in asthma: the ADITION non-interventional study

Area of Science:

• Respiratory Medicine
• Digital Health
• Pharmacoeconomics

Background:

• Poor adherence to asthma maintenance therapy negatively impacts patient outcomes.
• Digital adherence support systems offer a potential solution to improve medication compliance.
• This study investigates the role of digital support in asthma management.

Purpose of the Study:

• To evaluate asthma control and adherence in patients using mometasone furoate/indacaterol/glycopyrronium (MF/IND/GLY) with digital support.
• To compare these outcomes with patients using any inhaled corticosteroid/long-acting β2-agonist/long-acting muscarinic antagonist (ICS/LABA/LAMA) combination without digital support.

Main Methods:

• Prospective, non-interventional, multicentre, open-label study in adult asthma patients in Germany.
• Primary endpoint: change in Asthma Control Test (ACT) score at 6 months.
• Propensity score matching was used to compare outcomes between groups.

Main Results:

• No significant difference in ACT score improvement between the MF/IND/GLY with digital support group and the ICS/LABA/LAMA alone group after propensity matching.
• Moderate baseline adherence with limited changes observed throughout the study in both groups.
• Similar incidence of adverse events in both treatment arms.

Conclusions:

• Mometasone furoate/indacaterol/glycopyrronium with digital support provided comparable asthma control to standard ICS/LABA/LAMA therapy.
• Adherence showed minimal changes, indicating challenges in improving compliance with current digital tools.
• Further research is needed to optimize digital support systems for enhancing inhaler adherence in asthma.